Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abbott Laboratories (NYSE:ABT)

56.12
Delayed Data
As of Nov 21
 +0.83 / +1.50%
Today’s Change
37.38
Today|||52-Week Range
56.69
+46.11%
Year-to-Date

Today’s Trading

Previous close55.29
Today’s open55.45
Day’s range55.44 - 56.32
Volume4,612,991
Average volume (3 months)5,513,567
Market cap$96.2B
Dividend yield1.89%
Data as of 4:02pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)-47.25%
Earnings growth (this year)+13.35%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+2.20%
P/E ratio46.8
Price/Sales2.73
Price/Book3.97

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.33+0.40%
NVONovo Nordisk+0.32+0.62%
BMYBristol-Myers Squibb+0.44+0.72%
GSKGlaxoSmithKline-0.31-0.88%
Data as of 4:04pm ET, 11/21/2017

Financials

Next reporting dateJanuary 24, 2018
EPS forecast (this quarter)$0.73
Annual revenue (last year)$20.9B
Annual profit (last year)$1.4B
Net profit margin5.06%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian B. Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts